Now focusing on lung cancer, they mentioned in detail some of the regulators of MALAT1 (e.g., TDP-43, ESR2, Oct3/4) (Guo et al., 2015a; Jen et al., 2017; Yu et al., 2019), some genes regulated by MALAT1 (e.g., TP53, cleaved-PARP1, cleaved-CASP3, phospho-STAT3) (Tano et al., 2018; Yang et al., 2018), some miRNAs regulated by MALAT1 (e.g., hsa-miR-145, hsa-miR-204, hsa-miR-124-1) (Li et al., 2016; Li et al., 2018b; Yu et al., 2019) and MALAT1 behavior against treatment at clinical level. This evidence concerns the gene MALAT1 and lung carcinoma.